Abstract
Herein, we report the first case presentation of paraneoplastic myelofibrosis associated with cancer. Paraneoplastic syndromes occur in some patients with thoracic malignancies; however, myelofibrosis is not commonly seen in non-small cell lung cancer (NSCLC). We report a case of myelofibrosis in a patient with a new diagnosis of NSCLC that resolved after stereotactic ablative radiotherapy (SABR). In conclusion, NSCLC may evoke unexpected systemic effects that resolve with treatment.
Author supplied keywords
Cite
CITATION STYLE
Sloan, L., Naik, R. P., Umrau, K., Xian, R. R., Marrone, K. A., & Voong, K. R. (2022). Case Report: Hematologic Recovery Following Stereotactic Ablative Radiotherapy in a Patient With Early-Stage Non-Small Cell Lung Cancer and Paraneoplastic Myelofibrosis. Frontiers in Oncology, 12. https://doi.org/10.3389/fonc.2022.842620
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.